Zobrazeno 1 - 10
of 327
pro vyhledávání: '"A. Mertz-Nielsen"'
Autor:
Kiszka-Kanowitz, Marianne, Theede, Klaus, Thomsen, Sandra Bohn, Bjerrum, Jacob Tveiten, Brynskov, Jørn, Gottschalck, Ida Benedikte, Akimenko, Elena, Hilsted, Karen Lisa, Neumann, Anders, Wildt, Signe, Larsen, Lone, Munk, Jens Kristian, Ibsen, Per Holger, Janjua, Huma Gul Rehana, Gluud, Lise Lotte, Mertz-Nielsen, Anette
Publikováno v:
In eClinicalMedicine March 2022 45
Autor:
Marianne Kiszka-Kanowitz, Klaus Theede, Sandra Bohn Thomsen, Jacob Tveiten Bjerrum, Jørn Brynskov, Ida Benedikte Gottschalck, Elena Akimenko, Karen Lisa Hilsted, Anders Neumann, Signe Wildt, Lone Larsen, Jens Kristian Munk, Per Holger Ibsen, Huma Gul Rehana Janjua, Lise Lotte Gluud, Anette Mertz-Nielsen
Publikováno v:
EClinicalMedicine, Vol 45, Iss , Pp 101332- (2022)
Summary: Background: Retrospective studies suggest that for patients with ulcerative colitis (UC) combination therapy with low-dose azathioprine and allopurinol (L-AZA/ALLO) may result in higher remission rates than monotherapy with azathioprine (AZA
Externí odkaz:
https://doaj.org/article/97e99eefbcd243a1995ac82e77994a54
Publikováno v:
Scandinavian Journal of Gastroenterology; Jun2024, Vol. 59 Issue 6, p669-673, 5p
Autor:
Mads Damsgaard Wewer, Laura Arp, Melek Sarikaya, Oluf Krautwald Felding, Ida Vind, Gitte Pedersen, Anette Mertz-Nielsen, Marianne Kiszka-Kanowitz, Trine Boysen, Klaus Theede, Andreas Munk Petersen, Inge Nordgaard-Lassen, Flemming Bendtsen, Johan Burisch
Publikováno v:
Wewer, M D, Arp, L, Sarikaya, M, Felding, O K, Vind, I, Pedersen, G, Mertz-Nielsen, A, Kiszka-Kanowitz, M, Boysen, T, Theede, K, Petersen, A M, Nordgaard-Lassen, I, Bendtsen, F & Burisch, J 2022, ' The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020 ', Crohn's and Colitis 360, vol. 4, no. 4, otac041 . https://doi.org/10.1093/crocol/otac041
Background Patients with inflammatory bowel disease (IBD) who receive biologicals frequently experience lack or loss of response. Our aim was to describe the use and efficacy of biological therapy in a tertiary IBD center. Methods We included all bio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a79306536821e39118c173c97023eed7
https://curis.ku.dk/ws/files/338171159/otac041.pdf
https://curis.ku.dk/ws/files/338171159/otac041.pdf
Autor:
Wewer, Mads Damsgaard, Arp, Laura, Sarikaya, Melek, Felding, Oluf Krautwald, Vind, Ida, Pedersen, Gitte, Mertz-Nielsen, Anette, Kiszka-Kanowitz, Marianne, Boysen, Trine, Theede, Klaus, Petersen, Andreas Munk, Nordgaard-Lassen, Inge, Bendtsen, Flemming, Burisch, Johan
Publikováno v:
Crohn's & Colitis 360; Oct2022, Vol. 4 Issue 4, p1-10, 10p
Autor:
Kristine H. Allin, Johan Burisch, Tine Jess, Klaus Theede, Susanne Hansen, Sandra Bohn Thomsen, Camilla B. Jensen, Lise Lotte Gluud, Marianne Kiszka-Kanowitz, Anette Mertz Nielsen
Publikováno v:
Thomsen, S B, Allin, K H, Burisch, J, Jensen, C B, Hansen, S, Gluud, L L, Theede, K, Kiszka-Kanowitz, M, Nielsen, A M & Less, T 2020, ' Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease : A nationwide Danish cohort study ', European Journal of Gastroenterology and Hepatology, vol. 8, no. 1, pp. 68-76 . https://doi.org/10.1177/2050640619868387
BACKGROUND: Thiopurine and allopurinol in combination are associated with clinical remission in inflammatory bowel diseases but their influence on subsequent outcomes is unclear. We compared outcomes during exposure to both thiopurines and allopurino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b92c01a5531daae2b275fa57a40bd4
https://curis.ku.dk/portal/da/publications/outcome-of-concomitant-treatment-with-thiopurines-and-allopurinol-in-patients-with-inflammatory-bowel-disease(14d41a13-de3c-449d-8377-10f2f37d8f64).html
https://curis.ku.dk/portal/da/publications/outcome-of-concomitant-treatment-with-thiopurines-and-allopurinol-in-patients-with-inflammatory-bowel-disease(14d41a13-de3c-449d-8377-10f2f37d8f64).html
Autor:
Marianne Kiszka-Kanowitz, Sandra Bohn Thomsen, Anette Mertz Nielsen, Lise Lotte Gluud, Klaus Theede
Publikováno v:
European journal of gastroenterologyhepatology. 30(10)
Objective Two meta-analyses have found that the risk of relapse in Crohn's disease (CD) was ~40 and 50% 1 and 2 years, respectively, after withdrawal of anti-tumour necrosis factor-α (anti-TNFα). The aim of this study was to evaluate relapse rates
Publikováno v:
Journal of Crohn's and Colitis. 9:625-632
Background: Health-related quality of life [HRQoL] is impaired in ulcerative colitis and is correlated to clinical disease activity. The recent shift towards more objective treatment goals like mucosal healing generates a need for evaluating the asso
Autor:
R Lundquist, Tonny Karlsmark, Lise Tarnow, B. Jorgensen, A Nilsson, M Michelsen, M Zakrzewski, Anette Mertz Nielsen, Magnus Löndahl
Publikováno v:
Journal of Wound Care. 24:172-178
Objective: Leucopatch is a leukocyte and platelet-rich fibrin patch that provides concentrated blood cells and signal substances to the surface of an ulcer. It is produced by centrifugation of the patient's own venous blood. The aim of this pilot mul
Publikováno v:
Scandinavian Journal of Gastroenterology. 49:418-423
Monitoring active ulcerative colitis (UC) is essential for making correct and timely treatment decisions. The current monitoring is based on symptom scores and biochemical markers, among which the role of fecal calprotectin (FC) is debated. The aims